Share your videos with the world

Sign Up | Log In | Help  

   
 
Related Tags: auto  car  price  fixing  settlement  payout  money  legal  lawsuit  repairs  multivu  7982351  ketel  one  vodka  alcohol  perfect  ad  commercial  identity  theft  signature  multivu  7975151  hearing  fda  loss  hearing  aid  cochlear  limited  kanso  style  discrete  multivu  7658352  food  drug  administration  fda  abbott  tecnis  symfony  sight  eyes  treatment  cataracts  multivu  7870151  abbott  health  heart  procedure  fda  coronary  artery  disease  food  drug  administration  multivu  7826651  aspiresr  vns  therapy  fda  approval  epilepsy  drug  resistant  health  seizures  medication  doctor  multivu  7651751  fda  approval  boston  scientific  coronary  artery  disease  drug  research  science  health  multivu  7223456  abbott  idesign  nasa  lasik  hubble  telescope  james  webb  space  eye  vision  multivu  7571951  ytica  limited  pericoach  women  pelvic  bladder  health  kegel  muscle  exercise  training  medical  device  multivu  7543451  jadenu  novartis  iron  chelator  chelation  therapy  blood  transfusions  treatment  medicine  medication  multivu  7440151  after  the  fall  patricia  gussin  after  the  fall  by  patricia  gussin  book  trailer  medical  thriller  fiction  suspense  fda  sus  enteromedics  vbloc  vagal  blocking  maestro  system  obesity  weight  loss  hunger  medical  device  treatment  multivu  7269351 
Search // approval
Results 1-12 of 29 for ' approval ' (0 seconds)
The following is being released by the Notice Provider, Kinsella Media, LLC, about the lawsuit In re Automotive Parts Antitrust Litigation, MDL No. 2311. There is an update for affected purchasers in this lawsuit about certain vehicle components, as there have been additional Settlements that may affect their rights. Twelve additional Defendants have agreed to Settlements resolving claims that they fixed the price of certain vehicle components. (The Court previously approved settlements with 11 Defendants, totaling approximately $225 million.) The additional Settlements being presented for Court Approval total approximately $379 million. The lawsuits allege that Defendants fixed the price of certain vehicle components, causing millions of consumers and businesses from around the country to pay more for certain new or leased vehicles and replacement parts. A complete list of included parts is available at the website, www.AutoPartsClass.com. To view the multimedia release go to: http://www.multivu.com/players/English/7982351-auto-parts-class-action-settlements/
Categories // Miscellaneous 
Added: 417 days ago by MultiVuVideos
Runtime: 0m30s | Views: 66 | Comments: 0
Not yet rated
 

 

 

At the heart of Ketel One Vodka lies one family’s unwavering passion for crafting the world’s finest spirits. Inspired by over 325 years of distilling expertise, the Nolet family brings old-world pot still craft and modern distilling techniques together in one flawless process. From Joannes to Jacobus to Carolus Sr., creator of Ketel One Vodka, to Carolus Jr. and Bob Nolet today, each of the 11 generations of Nolet family distillers is tasked with upholding a legacy of distilling excellence. Some may consider the Nolets a little obsessive, but those individuals just don’t understand. Everything must be done with meticulous attention to detail, because the family name is riding on every bottle of Ketel One Vodka. “We take our work very seriously, not ourselves,” said Carl Nolet Jr., 11th Generation Nolet Family Distillery. “The stories we tell are all true and based on family events, beliefs and the pressure of upholding 11 generations of legacy for generations to come.” To view the multimedia release go to: http://www.multivu.com/players/English/7975151-ketel-one-vodka
Categories // Miscellaneous 
Added: 417 days ago by MultiVuVideos
Runtime: 0m30s | Views: 54 | Comments: 0
Not yet rated
 

 

 

Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, announces today it has received U.S. Food and Drug Administration (FDA) approval for its newest innovative hearing loss solution, Kanso. The Kanso Sound Processor provides a distinct new way for cochlear implant users to hear. Unlike most hearing aids and current cochlear implant sound processors that are worn on the ear, Kanso is a small, off-the-ear hearing device that provides a more discreet hearing solution and delivers the same hearing experience as a behind-the-ear sound processor. The name Kanso is a Japanese word for ‘simplicity,’ and it was selected in recognition of Kanso’s all-in-one design. The Kanso Sound Processor features a single on/off button with no cables so it is easy to use. It is worn on the user’s head with nothing behind the ear, adding greater comfort for those with glasses, and it can be easily hidden under or blended within a user’s hair. To view the multimedia release go to: http://www.multivu.com/players/English/7658352-cochlear-kanso-fda-approval/
Categories // Miscellaneous 
Added: 501 days ago by MultiVuVideos
Runtime: 1m51s | Views: 102 | Comments: 0
Not yet rated
 

 

 

Abbott announced today that the U.S. Food and Drug Administration (FDA) has approved the Tecnis Symfony® Intraocular Lenses for the treatment of cataracts. The first in a new category of intraocular lenses (IOLs), the Tecnis Symfony lenses are the only lenses in the United States that provide a full range of continuous high-quality vision following cataract surgery, while also mitigating the effects of presbyopia by helping people focus on near objects. The FDA approval includes a version of the lens for people with astigmatism, the Tecnis Symfony Toric IOL. Cataracts are a common condition, with almost 4 million cataract surgeries performed each year, and that number is expected to increase.1 By age 80, more than half of all Americans either have a cataract or have had cataract surgery.2 However, cataracts do not just impact seniors. In 2016 it is estimated that nearly one in four cataract surgeries will be performed on people younger than 65.1 Many people who have cataracts experience other problems with their vision, such as presbyopia and astigmatism, which the Symfony lenses also address. Presbyopia, which affects most people over age 40, means people have lost the ability to focus on objects up close and often require glasses to perform near visual tasks. Astigmatism is when the cornea is misshapen, which causes blurry or distorted vision. To view the multimedia release go to: http://www.multivu.com/players/English/7870151-abbott-intraocular-lenses/
Categories // Miscellaneous 
Added: 554 days ago by MultiVuVideos
Runtime: 0m35s | Views: 117 | Comments: 0
Not yet rated
 

 

 

Abbott announced today that the U.S. Food and Drug Administration has approved the company’s Absorb bioresorbable heart stent, making the first-of-its-kind medical device commercially available to treat people with coronary artery disease in the United States. Absorb is the only fully dissolving stent approved for the treatment of coronary artery disease, which affects 15 million people in the United States and remains a leading cause of death worldwide, despite decades of therapeutic advances. While stents are traditionally made of metal, Abbott’s Absorb stent is made of a naturally dissolving material, similar to dissolving sutures. Absorb disappears completely in approximately three years, after it has done its job of keeping a clogged artery open and promoting healing of the treated artery segment. By contrast, metal stents are permanent implants that restrict vessel motion for the life of the person treated. To view the multimedia release go to: http://www.multivu.com/players/English/7826651-abbott-fda-approval-stent/
Categories // Miscellaneous 
Added: 562 days ago by MultiVuVideos
Runtime: 1m33s | Views: 139 | Comments: 0
Not yet rated
 

 

 

Following FDA approval of the AspireSR® generator for the VNS Therapy® system in June 2015, more than a thousand patients with drug-resistant epilepsy across the United States have received this new treatment option. Many of these patients are experiencing benefits which have positively impacted their lives – and are sharing their stories during Epilepsy Awareness Month with the hope of encouraging others to seek new treatments for drug-resistant epilepsy. Numerous hospitals nationwide have begun providing the AspireSR device to patients with drug-resistant epilepsy – a condition that affects as many as one-third of people with epilepsy, causing them to have seizures in spite of treatment with antiepileptic medications. The VNS Therapy system is a minimally invasive option in which a medical device is placed under the skin in the upper chest area during an outpatient procedure. The device sends mild electrical pulses through the vagus nerve to areas of the brain known to be associated with seizures. The new AspireSR generator takes the VNS Therapy technology a step further – detecting relative heart-rate increases that are often associated with seizures in people with epilepsy and providing responsive stimulation in an attempt to stop and shorten seizures and improve recovery. To view the multimedia release go to: http://www.multivu.com/players/English/7651751-livanova-aspiresr-treatment/
Categories // Miscellaneous 
Added: 800 days ago by MultiVuVideos
Runtime: 5m25s | Views: 192 | Comments: 0
    
 

 

 

Boston Scientific (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval for the SYNERGY™ Bioabsorbable Polymer Drug-Eluting Stent System (BP-DES) for the treatment of coronary artery disease. With this FDA approval, Boston Scientific will commence commercialization of the first and only BP-DES in the U.S. Notably, both the drug coating and the polymer – which modulates drug release – are fully absorbed shortly after drug elution is complete at three months. The SYNERGY Stent provides synchronized drug and polymer absorption. It is designed to enable more rapid and complete arterial healing, and to thereby reduce the risk of complications associated with long-term polymer exposure compared to currently-used drug-eluting stents (DES) with permanent polymers. To view the multimedia release go to: http://www.multivu.com/players/English/7223456-boston-scientific-fda-approval-synergy/
Categories // Science and Technology 
Added: 838 days ago by MultiVuVideos
Runtime: 0m45s | Views: 179 | Comments: 0
Not yet rated
 

 

 

Abbott announced today the U.S. Food and Drug Administration approval and launch of the iDesign Advanced WaveScan Studio System. The system acts as the "brain" of the LASIK procedure, generating a high-definition scan that measures and maps irregularities of the eye that may impact vision. From these measurements, the iDesign System creates an accurate and personalized LASIK treatment plan based on the unique "blueprint" of each person’s eyes. The iDesign System captures more than 1,200 micro readings of the eye, as well as identifying the shape of the cornea, its curvature, how light passes through the eye and pupil diameter under different lighting conditions – all in one, three-second scan that can be used to precisely correct vision. The development of the sensor technology within the iDesign System was the result of an earlier discovery by Abbott scientists, which NASA used to accurately measure and shape the mirrors in the James Webb Space Telescope to ensure it will transmit high resolution images of deep space back to earth. The telescope is scheduled to launch in 2018. To view the Multimedia News Release, please go to http://www.multivu.com/players/English/7571951-abbott-idesign-system-3-d-eye-map/
Categories // Science and Technology 
Added: 915 days ago by MultiVuVideos
Runtime: 2m25s | Views: 261 | Comments: 0
Not yet rated
 

 

 

The millions of women who experience bladder leakage now have a new option to strengthen and tone away their problem instead of covering it up with pads. The PeriCoach System is a discreet device and smartphone app that helps women perform at-home pelvic floor muscle training, exercises recommended by the American College of Physicians as first-line treatment for urinary incontinence. PeriCoach is the only system that includes a web portal allowing clinicians to remotely monitor their patients’ progress. To view the Multimedia News Release, go http://www.multivu.com/players/English/7543451-pericoach-fda-approval/
Categories // People and Blog 
Added: 942 days ago by MultiVuVideos
Runtime: 1m11s | Views: 204 | Comments: 0
Not yet rated
 

 

 

Novartis announced today that the US Food and Drug Administration (FDA) has approved Jadenu™ (deferasirox) tablets, a new oral formulation of Exjade® (deferasirox) tablets for oral suspension, for the treatment of chronic iron overload due to blood transfusions in patients 2 years of age and older, and chronic iron overload in non-transfusion-dependent thalassemia syndromes (NTDT) in patients 10 years of age and older. Jadenu is the only once-daily oral iron chelator that can be swallowed whole. To view the Multimedia News Release, go to http://www.multivu.com/players/English/7440151-novartis-jadenu-fda-approval/
Added: 1026 days ago by MultiVuVideos
Runtime: 0m53s | Views: 246 | Comments: 0
Not yet rated
 

 

 

An injury ends Laura Nelson’s career as a surgeon. Now, as Vice President of a pharmaceutical company, Laura works to finalize the approval of a groundbreaking new drug. But her efforts are being thwarted by a malicious FDA employee who will stop at nothing to prevent the approval, and Laura is standing directly in his path. Find out more about the author here- http://patriciagussin.com/ and check out the book here http://oceanviewpub.com/after-the-fall/. After the Fall by Patricia Gussin. Thriller
Categories // Miscellaneous 
Added: 1071 days ago by cosproductions
Runtime: 1m-0s | Views: 245 | Comments: 0
     
 

 

 

EnteroMedics Inc. (NASDAQ: ETRM) today announced that the U.S. Food and Drug Administration (FDA) has approved VBLOC® vagal blocking therapy, delivered via the Maestro® System, for the treatment of adult patients with obesity who have a Body Mass Index (BMI) of at least 40 to 45 kg/m2, or a BMI of at least 35 to 39.9 kg/m2 with a related health condition such as high blood pressure or high cholesterol levels, and who have tried to lose weight in a supervised weight management program within the past five years. The Maestro System is the first new medical device to be approved by the FDA for obesity in over ten years. EnteroMedics anticipates that the device will be available, on a limited basis, at select Bariatric Centers of Excellence in the U.S. this year. The Maestro System has received CE Mark and is listed on the Australian Register of Therapeutic Goods. To view the Multimedia News Release, go to http://www.multivu.com/players/English/7269351-enteromedics-fda-approval-vbloc-maestro-system-weight-loss-device/
Added: 1102 days ago by MultiVuVideos
Runtime: 0m24s | Views: 234 | Comments: 0
Not yet rated
 

 

 

Page 1 of 3  |  Go to page    Next» LAST»»



About Us   |   Help  |   Advertise on ClipMoon   |   Terms of Use   |   Privacy Policy   |   Copyright   |   Contact   |   Link us   |   RSS 
Copyright © 2007-2018 ClipMoon.com. All rights reserved.